Tzar Labs

Tzar Labs is a medical laboratory aiming to redefine diagnostics by detecting cancer precisely and accurately through a non-invasive blood test. To date, our scientists have developed the following unique blood-based technologies:

1. HrC Genomics - a simple blood-based approach to indicating the absence or risk of cancer presence.

2. B-Cube Onco - a comprehensive genetic analysis of all organs impacted by cancer.

3. All Organ Biopsy - RNA transcriptomics analysis of the signalling pathways about cancer, diabetes, cardiovascular & neurodegenerative disease, from a blood sample.

HrC Genomics

Using a proprietary blood processing protocol developed by our team of scientists, we can isolate and enrich a special class of pluripotent stem cells, including cancer stem cells, from blood. The enriched cells are then processed using Next Generation Sequencing (NGS) technology to identify highly-specific markers (including RNA, protein and molecular markers) which are known to be key hallmarks of cancer initiation.

These markers show up in blood as early as 12-18 months before symptoms or tumour development, which means HrC Genomics detects the risk of cancer presence earlier than any other known technology.

From the data generated from the NGS processing, we can provide an accurate indication of the risk of cancer presence, ranging from no-risk, negligible-risk, low-risk, moderate-risk, through to high-risk.

Our scientists also believe that they have discovered the commonality that exists between all types and sub-types of cancer, in that they all initiate in the same way, which means that HrC Genomics is potentially the world’s first pan-cancer blood test.

B-Cube Onco

B-Cube Onco provides a Full Cancer Health Check of all the organs impacted by cancer. This is possible due to the discovery by our scientists of pluripotent progenitor stem cells circulating in peripheral blood. This type of stem cell contains the signature of the organ from where it originated, meaning that once the transcriptome analysis of the cell has been performed, the following detailed information relating to the tumour(s) can be obtained:

• Genetic Mutations

• Altered Expressions

• Dysregulated Pathways

B-Cube Onco is a simple blood test that provides all the information required to guide treatment for all organs impacted by cancer, without the need for a tissue biopsy.

Being a simple blood test, Onco B3 can be performed as often as required to help monitor responsiveness to treatment, as well as being able to conclusively confirm remission for cancer survivors.

All Organ Biopsy

All Organ Biopsy is a full body health check of all the organs in the body with relation to cancer, diabetes, neurodegenerative and cardiovascular disease. Recording this information on an annual or bi-annual basis can provide an overview of an individual's health status with a view to preventing illness through intervention.

For further information on HrC Genomics, B-Cube Onco or All Organ Biopsy, please contact Steve Smith at steve@tzarlabs.com